Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk

European Journal of Cancer

Volumn 42, Issue 16, 2006, Pages 2833-2837

  Andersson, Patiyan ^a   Varenhorst, Eberhard ^a   Söderkvist, Peter ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Androgen receptor; CAG repeat; Prostate cancer; Vitamin D receptor

Indexed keywords

ANDROGEN RECEPTOR; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; STUDENT T TEST; TISSUE SECTION;

AGED; AGED, 80 AND OVER; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, CALCITRIOL; RISK FACTORS; TERMINAL REPEAT SEQUENCES;

EID: 33750075191     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.06.030     Document Type: Article

References (29)

1. Cude K.J., Dixon S.C., Guo Y., Lisella J., and Figg W.D. The androgen receptor: genetic considerations in the development and treatment of prostate cancer. J Mol Med 77 (1999) 419-426
2. Chamberlain N.L., Driver E.D., and Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22 (1994) 3181-3186
3. Zeegers M.P., Kiemeney L.A.L.M., Nieder A.M., and Ostrer H. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 13 (2004) 1765-1771
4. Ekman P., Grönberg H., Matsuyama H., Kivineva M., Bergerheim U.S.R., and Li C. Links between genetic and environmental factors and prostate cancer risk. Prostate 39 (1999) 262-268
5. Morrison N.A., Qi J.C., Tokita A., et al. Prediction of bone density from vitamin D alleles. Nature 367 (1994) 284-287
6. Ntais C., Polycarpou A., and Ioannidis J. Vitamin D receptor polymorphisms and risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 12 (2003) 1395-1402
7. Lundin A.C., Söderkvist P., Eriksson B., Bergman-Jungeström M., and Wingren S. Association of breast cancer progression with vitamin D receptor gene polymorphism. Cancer Res 59 (1999) 2332-2334
8. Irvine R.A., Yu M.C., Ross R.K., and Coetzee G.A. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55 (1995) 1937-1940
9. Ingles S.A., Ross R.K., Yu M.C., et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89 (1997) 166-170
10. Hardy D.O., Scher H.I., Bogenreider T., et al. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. Clin Endocrinol Metab 81 (1996) 4400-4405
11. Giovannucci E., Stampfer M.J., Krithivas K., et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94 (1997) 3320-3323
12. Hakimi J.M., Schoenberg M.P., Rondinelli R.H., Piantadosi S., and Barrack E.R. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res 3 (1997) 1599-1608
13. Stanford J.L., Just J.J., Gibbs M., et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57 (1997) 1194-1198
14. Hsing A.W., Gao Y.T., Wu G., et al. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study. Cancer Res 60 (2000) 5111-5116
15. Gsur A., Preyer M., Haidinger G., et al. Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. Carcinogenesis 23 (2002) 1647-1651
16. Correa-Cerro L., Wohr G., Haussler J., et al. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet 7 (1999) 357-362
17. Edwards S.M., Badzioch M.D., Minter R., et al. Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. Int J Cancer (Pred Oncol) 84 (1999) 458-465
18. Mir K., Edwards J., Paterson P.J., Hehir M., Underwood M.A., and Barlett J.M. The CAG trinucleotide repeat length in the androgen receptor does not predict the early onset of prostate cancer. BJU Int 90 (2002) 573-578
19. Chen C., Lamharzi N., Weiss N.S., et al. Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiol Biomarkers Prev 11 (2002) 1033-1040
20. Mononen N., Ikonen T., Autio V., et al. Androgen receptor CAG polymorphism and prostate cancer risk. Hum Gent 111 (2002) 166-171
21. Giovannucci E. Is the androgen receptor CAG repeat length significant for prostate cancer?. Cancer Epidemiol Biomarkers Prev 11 (2002) 985-986
22. Medeiros R., Morais A., Vasconcelos A., et al. The role of vitamin D receptor gene polymorphisms in the suseptibilty to prostate cancer of a European population. J Hum Genet 47 (2002) 413-418
23. Correa-Cerro L., Berthon P., Haussler J., et al. Vitamin D polymorphisms as markers in prostate cancer. Hum Genet 105 (1999) 281-287
24. Blazer D.G., Umbach D.M., Bostick R.M., and Taylor J.A. Vitamin D receptor polymorphisms and prostate cancer. Mol Carcino 27 (2000) 18-23
25. Gsur A., Madersbacher S., Haidinger G., et al. Vitamin D receptor gene polymorphism and prostate cancer risk. Prostate 51 (2002) 30-34
26. Ma J., Stampfer M.J., Gann P.H., et al. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev 7 (1998) 385-390
27. Hamasaki T., Inatomi H., Katoh T., Ikuyama T., and Matsumoto T. Significance of vitamin D gene polymorphism for risk and disease severity of prostate cancer and benign prostatic hyperplasia in Japanese. Urol Int 68 (2002) 226-231
28. Habuchi T., Suzuki T., Sasaki R., et al. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res 60 (2000) 305-308
29. Taylor J.A., Hirvonen A., Watson M., Pittman G., Mohler J.L., and Bell D.A. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 55 (1996) 4108-4110